Introduction
============

Colon cancer is one of the most common types of cancer in developed countries, and surgery is the only curative treatment. Successful laparoscopy-assisted sigmoidectomy for colon cancer was first described in 1991[@B1] and has since then been widely applied by surgeons to treat patients with colon cancer.

Several articles have reported the short-term advantages of laparoscopy-assisted colectomy (LAC) over conventional open colectomy (OC) and have concluded that laparoscopic surgery causes less pain, results in better pulmonary function, shortens the duration of postoperative ileus, reduces fatigue, and offers a better quality of life[@B2]-[@B5]. However, the benefits of LAC have remained controversial because the long-term outcomes have not yet been clarified. To accurately evaluate the efficacy of laparoscopic surgery for colon cancer, the short- and long-term outcomes of laparoscopic surgery must be compared to those of open surgery. For short-term outcomes, perioperative variables, pathologic factors, and the cost of surgery should be examined. For long-term outcomes, long-term oncologic results are the primary endpoint of interest. The long-term oncologic outcomes of LAC, such as tumor recurrence rate and mortality rate, have been published over time[@B6]-[@B9]. Several randomized control trials (RCTs) that compare LAC with OC have been reported [@B6]-[@B25]. Therefore, we conducted a meta-analysis of the data obtained from these RCTs and compared the short- and long-term outcomes of LAC and OC by considering several factors.

Materials and methods
=====================

Literature search
-----------------

To identify papers relevant to our study, we searched through the major medical databases such as MEDLINE, EMBASE, Science Citation Index, and Cochrane Controlled Trial Register for studies published between January 1990 and October 2011. The following search terms were used: "laparoscopy," "laparoscopy-assisted," "surgery," "colectomy," and "colon cancer." Furthermore, we limited our literature search to randomized controlled trials. We treated studies that were part of a series as a single study. The appropriate data from such study series were used for this meta-analysis. This meta-analysis was prepared in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement[@B26] (Fig.[1](#F1){ref-type="fig"}).

Inclusion criteria
------------------

To enter this meta-analysis, studies had to: (1) be described in English (2) be randomized controlled trials (3) compare laparoscopic and open conventional surgery for colon cancer (4) report on at least one of the outcome measures mentioned below.

Data extraction
---------------

Three researchers (H.O., Y.T., and Y.A.) extracted data from each article by using a structured sheet and entered the data into a database. Because this analysis was based on the intention-to-treat principle[@B27], all patients converted from the laparoscopic group to the conventional open surgery group remained in the laparoscopic group for analysis. We conducted separate meta-analyses for 2 different postoperative time periods: short-term and long-term. For the short-term analysis, we collected data on operation time, estimated blood loss, number of transfused patients, number of dissected lymph nodes, time to resumption, hospital stay, incision length, overall postoperative complications, ileus, anastomotic leakage, perioperative mortality, circumferential resection margin, oral resection margin, distal resection margin, and cost of surgery. We also examined the relationship between the conversion rate from laparoscopic to open surgery and single-institution versus multicenter trials. For the oncologic results in the long-term analysis, we used data on the rate of overall recurrence, local recurrence, distant metastasis, peritoneal dissemination, wound-site recurrence, overall mortality, and cancer-related mortality. If necessary, we contacted the authors of the original article to collect further information.

Assessment of study quality
---------------------------

The quality of the randomized controlled trials was assessed using Jadad\'s scoring system[@B28]. Two reviewers (H.O., Y.T.) assessed all studies that met the inclusion criteria (Table [1](#T1){ref-type="table"}).

Statistical analysis
--------------------

Weighted mean differences (WMDs) and odds ratios (ORs) were used for the analysis of continuous and dichotomous variables, respectively. Random-effects models were used to identify heterogeneity between the studies[@B29], and the degree of heterogeneity was assessed using the χ^2^ test. For the analysis of the conversion rate, the χ^2^ test was used. The confidence interval (CI) was established at 95%, and p values of less than 0.05 were considered to indicate statistical significance.

As the cost data of 1 article[@B21] were precious and had neither a range nor any other measure of dispersion, the standard deviation (SD) was estimated by halving the mean[@B30]. One Euro and British pound were converted to 1.4 and 1.6 US dollars, respectively. Statistical analyses were performed using the Review Manager (RevMan) software version 5.1.4 provided by the Cochrane Collaboration, Copenhagen, Denmark.

Results
=======

We identified 12 RCTs that compared LAC and OC for colon cancer[@B6]-[@B25]. The characteristics of each RCT are presented in Table [1](#T1){ref-type="table"}. Our meta-analysis included 4614 patients with colon cancer; of these, 2444 had undergone LAC, and 2170, OC. The results of the outcomes over short- and long-term periods are shown in Fig. [2](#F2){ref-type="fig"} and Fig. [3](#F3){ref-type="fig"}, respectively.

Short-term outcomes
-------------------

Of the 12 RCTs, 5 reported the operative duration; in all 5 reports, the operative duration was significantly longer for LAC than for OC. Our analysis showed that the operative duration for LAC was significantly longer than that for OC by 42.08 min (WMD ­­= 42.08; 95% CI = 29.87 to 54.30; p \< 0.00001). Blood loss in patients who underwent LAC was significantly lesser than that in patients who underwent OC, by an average volume of 103.9 ml (WMD = -103.90; 95% CI = -180.88 to -26.91; p = 0.008). There was no significant difference in the number of transfused patients. We found no significant difference in the number of dissected lymph nodes between LAC and OC groups. The duration of hospital stay and the time to oral diet were significantly shorter with LAC than with OC (p = 0.01 and \< 0.00001, respectively). The incision length was significantly shorter by 11.77 cm in LAC than in OC. The rate of the overall postoperative complications was significantly lower in LAC than in OC (OR = 0.73; 95% CI =0.56 to 0.95; p = 0.02). In examining the details of them, we found that the rate of ileus was significantly lower in LAC than in OC (OR = 0.40; 95% CI =0.25 to 0.66; p = 0.0003). The rate of anastomotic leakage between the 2 groups was insignificant. We also found no significant differences in perioperative mortality between the 2 groups when we pooled the data for LAC and OC for colon cancer.

Pathological factors
--------------------

In an analysis of pooled data, we found that there was no significant difference in the circumferential resection margin between the 2 groups. There was no significant difference in the oral and distal resection margin.

Cost of surgery
---------------

In an analysis of the total cost of surgery, there was no significant difference between the 2 groups.

Conversion rate
---------------

Twelve articles reported data on the conversion rate from laparoscopic to open surgery, which ranged from 3 to 46.4% (Table [1](#T1){ref-type="table"}). In an analysis of the conversion rate, there was no significant difference between the trials performed by a single institution and those performed on a multicenter basis (p = 0.31).

Long-term outcomes
------------------

With respect to overall recurrence, local recurrence, distant metastasis, and peritoneal dissemination, the differences between the 2 groups were insignificant. Our analysis of the wound-site recurrence between the LAC and OC groups indicated no significant difference. There was also no significant difference in the overall and cancer-related mortality between the 2 groups.

Heterogeneity
-------------

In the short-term period, significant heterogeneity was detected between studies for the following 6 factors: operative time, intraoperative blood loss, duration of hospital stay, incision length, overall postoperative complications, and cost of surgery. In the long-term periods, no significant heterogeneity was detected between studies.

Discussion
==========

In short-term periods, laparoscopic surgery for colon cancer is associated with a significantly longer operative time, but significantly less intraoperative blood loss compared with conventional open surgery. These results are consistent with those of recent randomized controlled trials [@B8],[@B13],[@B15]. Potential explanations for the abovementioned results include meticulous dissection facilitated by instruments for laparoscopic surgery and videoscopic magnification. The similarity of oncological outcomes such as circumferential, oral, and distal resection margin and the number of harvested lymph nodes between the 2 groups indicates identical quality of the operative techniques. Patients who underwent LAC resumed oral intake significantly earlier and had significantly shorter hospital stays than did patients who underwent OC; this finding suggests that LAC leads to faster recovery. The rate of postoperative complications was significantly lower in LAC than on OC. In examining the details, we found the rate of ileus significantly lower in LAC than in OC. Gutt et al. describe that laparoscopic surgery reduces adhesion formation compared with open surgery. Because laparoscopic procedures reduce the overall degree of trauma to the abdominal wall, intraabdominal operative site, and distant intraabdominal organs, they potentially have an advantage in reducing the formation of postoperative adhesion[@B31]. The abovementioned suggests that LAC may be safer and more feasible than OC.

In the analysis of the total cost of surgery, we found no significant overall difference between LAC and OC. However, the operating costs were higher and the hospitalization costs were lower for LAC compared with OC.

Several reports have shown that conversion from laparoscopic to open surgery is associated with inferior surgical outcomes[@B6]. In this analysis, the conversion rate was not significantly related to the type of study, i.e., single-institution or multicenter. The CLASICC trial reported that tumor infiltration/fixation and obesity were the most common reason for conversion[@B13].

In the long-term period, we found no significant difference in overall recurrence, local recurrence, distant metastasis, and peritoneal dissemination between the 2 surgery groups. There was also no significant difference in wound-site recurrence between the 2 groups. No significant difference was found in overall and cancer-related mortality. The abovementioned findings suggest that LAC is comparable to OC with respect to long-term oncologic results. Lacy et al. reported that there was a tendency of higher cancer-related and overall survival for LAC[@B9], but our meta-analysis of the pooled data did not show this difference.

Significant heterogeneity was observed for operative time, intraoperative blood loss, duration of hospital stay, incision length, overall postoperative complications, and cost of surgery in the short-term period. The reason for the observed heterogeneity in operative time, intraoperative blood loss, and overall postoperative complications may be variations in the skill of the surgeon and the condition of the tumor. Differences in the clinical approach at different institutions may have caused the heterogeneity in the duration of hospital stay and incision length. Significant heterogeneity for cost of surgery may be caused by differences in medical fees among countries.

In conclusion, this meta-analysis showed that laparoscopic surgery for colon cancer is associated with a reduction in intraoperative blood loss, earlier resumption of oral intake, shorter duration of hospital stay, and rate of postoperative complications concluding ileus over the short-term, but is associated with similar short-term and long-term oncologic outcomes compared to conventional open surgery. Therefore, it is suggested that laparoscopic surgery may be preferred to conventional open surgery for colon cancer.
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Meta-analysis of the short-term period for colon cancer
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Meta-analysis of the long- term oncologic results for colon cancer
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Characteristics of randomized controlled trials.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  authors                         Year               country                                          number of reference   institutions of the study   Conversion rate (%)                    Study size (n)   follow-up period (months)   Randomization          Double Blinding   Withdrawals and dropouts   Jadad\'s score   
  ------------------------------- ------------------ ------------------------------------------------ --------------------- --------------------------- -------------------------------------- ---------------- --------------------------- ---------------------- ----------------- -------------------------- ---------------- ---
  Braga et al.                    2010               Italy                                            10                    single center               5.2(7/134)                             134              134                         73 months (median)     2                 2                          1                5

  CLASICC trial                   2010, 2007, 2005   UK                                               6, 7, 13, 21          multicenter (27)            25(61/246)                             526              268                         56.3 months (median)   2                 2                          1                5

  COLOR trial                     2009, 2005         Sweden,\                                         14, 15                multicenter (29)            19(102/534)                            534              542                         53 months (median)     2                 2                          1                5
                                                     Netherlands, Spain, Italy, France, UK, Germany                                                                                                                                                                                                                              

  COST trial                      2004               USA and Canada                                   16, 18                multicenter (48)            21(90/435)                             435              428                         7 years (median)       2                 2                          1                5

  Curet et al.                    2000               USA                                              17                    single center               28(7/25)                               25               18                          4.9 years (mean)       2                 2                          1                5

  ALCCaS trial (Hewett et al.)    2008               Australia and New Zealand                        24                    multicenter (31)            14.6(43/294)                           294              298                         unknown                2                 0                          1                3

  Kaiser et al.                   2004               USA                                              22                    single center               46.4(13/28)                            28               20                          35 months (median)     2                 0                          1                3

  Barcelona trial (Lacy et al.)   2008               Spain                                            8, 9                  single center               11(12/111)                             111              108                         95 months (median)     2                 2                          1                5

  Liang at al.                    2006               Taiwan                                           19                    single center               3(4/135)                               135              134                         40 months (median)     2                 2                          1                5

  Mirza et al.                    2008               UK                                               20                    single center               17 (19/113) concluding rectal cancer   116              117                         48 months (median)     1                 0                          0                1

  Pascual et al.                  2011               Spain                                            23                    single center               12(7/60)                               60               60                          41 months (median)     2                 2                          1                5

  Winslow et al                   2002               USA                                              25                    single center               15(7/46)                               46               43                          30.1 months (mean)     2                 0                          1                3
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

UK: United Kingdom, US: United States of America
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